e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Pulmonary mechanics and gas exchange
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diffusing capacity for nitric oxide and capillary blood volume in patients with idiopathic interstitial pneumonia
L. Stervinou, T. Perez, V. Debroucker, R. Neviere, B. Wallaert (Lille, France)
Source:
Annual Congress 2008 - Pulmonary mechanics and gas exchange
Session:
Pulmonary mechanics and gas exchange
Session type:
Thematic Poster Session
Number:
733
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Stervinou, T. Perez, V. Debroucker, R. Neviere, B. Wallaert (Lille, France). Diffusing capacity for nitric oxide and capillary blood volume in patients with idiopathic interstitial pneumonia. Eur Respir J 2008; 32: Suppl. 52, 733
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009
Diffusing capacity of the lung for nitric oxide and carbon monoxide: Influence of alveolar volume
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Standardization of pulmonary diffusing capacity for nitric oxide
Source: International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring
Year: 2017
Bronchial blood flow is normal in COPD patients and is positevily correlated with exhaled nitric oxide and the diffusion of carbon monoxide
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006
Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function
Source: Eur Respir J 2001; 17: 934-938
Year: 2001
A small amount of inhaled nitric oxide does not increase lung diffusing capacity
Source: Eur Respir J 2006; 27: 1251-1257
Year: 2006
Reference equations for pulmonary diffusing capacity of carbon monoxide and nitric oxide in adult Caucasians
Source: Eur Respir J, 52 (1) 1500677; 10.1183/13993003.00677-2015
Year: 2018
Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Lung diffusing capacity for nitric oxide and carbon monoxide: methodological issues and reproducibility in patients with cystic fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 325s
Year: 2007
Intra-session and inter-session variability of nitric oxide pulmonary diffusing capacity in patients with cystic fibrosis
Source: International Congress 2017 – Discussion of techniques and technologies in lung function
Year: 2017
Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
The nitric oxide diffusing capacity strongly depends on alveolar volume
Source: Eur Respir J 2005; 26: Suppl. 49, 262s
Year: 2005
Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients
Source: Eur Respir J 2009; 34: 138-144
Year: 2009
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Source: Eur Respir J 2007; 30: 26-30
Year: 2007
Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis
Source: Eur Respir J, 50 (4) 1701008; 10.1183/13993003.01008-2017
Year: 2017
Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1386-1395
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept